Perioperative management of antiplatelet-drugs in cardiac surgery.
The management of coronary patients scheduled for a coronary artery bypass grafting (CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has been shown that withdrawal of antiplatelet drugs is associated with an increased risk of a thrombotic event, but surgery under an altered platelet function also means an increased risk of bleeding in the perioperative period. Because of the conflict recommendations, this review article tries to evaluate the outcome of different perioperative antiplatelet protocols in patients with coronary artery disease undergoing CABG.
Ferrandis
Raquel
R
Department of Anaesthesiology and Critical Care Medicine, Hospital Clínic Universitari, València, Spain.
Llau
Juan V
JV
Mugarra
Ana
A